Cora Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $907K | Buy |
1,163
+130
| +13% | +$101K | 0.4% | 40 |
|
|
2025
Q1 | $853K | Buy |
1,033
+21
| +2% | +$17.3K | 0.41% | 42 |
|
|
2024
Q4 | $781K | Buy |
1,012
+35
| +4% | +$27K | 0.38% | 47 |
|
|
2024
Q3 | $866K | Buy |
977
+36
| +4% | +$31.9K | 0.43% | 45 |
|
|
2024
Q2 | $852K | Buy |
941
+7
| +0.7% | +$6.34K | 0.44% | 42 |
|
|
2024
Q1 | $726K | Sell |
934
-62
| -6% | -$48.2K | 0.39% | 47 |
|
|
2023
Q4 | $580K | Sell |
996
-2
| -0.2% | -$1.17K | 0.34% | 49 |
|
|
2023
Q3 | $536K | Sell |
998
-112
| -10% | -$60.2K | 0.36% | 49 |
|
|
2023
Q2 | $521K | Buy |
1,110
+154
| +16% | +$72.2K | 0.35% | 53 |
|
|
2023
Q1 | $328K | Buy |
956
+26
| +3% | +$8.93K | 0.24% | 56 |
|
|
2022
Q4 | $340K | Buy |
+930
| New | +$340K | 0.23% | 51 |
|